Follow us:

REPRODIVAC - Next-generation vaccines and diagnostics to prevent livestock reproductive diseases of worldwide impact

Infected cells
Rational antigen selection and vaccine design
Antigen production
Diagnostic assay development
Vaccine development

REPRODIVAC project aims to develop innovative vaccines and diagnostics for endemic and zoonotic reproductive pathogens of livestock to improve animal welfare, reduce antimicrobial usage in farming, protect public health with a ‘One Health’ perspective, and strengthen the profitability of food animal systems. The new vaccines and diagnostics will be further developed and made accessible to users by the industrial partners involved in the project.  Thereby by using the latest technologies in vaccine and diagnostic development REPRODIVAC will improve animal health and welfare, productivity and sustainability of the livestock sector, as well as human health.

NEWS & EVENTS

Upcoming Events

There are no upcoming events

Project Partner

ENEA - Agenzia Nazionale per le Nuove Tecnologie
WUR - Wageningen University & Research, the Netherlands
UDL University of Lleida, Spain
CEP - Centre D’estudis Porcins, Spain
CEVA - Ceva Animal Health, France
FLI - Friedrich Loeffler Institut, Germany
CITA - Centro De Investigacion Y Tecnologia Agroalimentaria De Aragón, Spain
UNAV - University of Navarra, Spain
UMU - University of Murcia, Spain
EPFL - École Polytechnique Fédérale de Lausanne, Switzerland
GSP - Associacio Porcsa-Grup de Sanejament Porcì, Spain
CZV - 12 CZ Veterinaria S.A. - CZ Vaccines, Spain
GDX - Global DX Ltd, United Kingdom
TPI - Pirbright Institute United Kingdom
MRI - Moredun Research Institute’ United Kingdom
ENSL - Ecole Normale Superieure de Lyon, France

REPRODIVAC has received funding from the European Union’s Horizon Europe research and innovation programme under Grant Agreement No. 101060813. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or other granting authorities. Neither the European Union nor the other granting authorities can be held responsible for them.

REPRODIVAC has received funding from the European Union’s Horizon Europe research and innovation programme under Grant Agreement No. 101060813. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or other granting authorities. Neither the European Union nor the other granting authorities can be held responsible for them.
Feedback